Drugs / D935
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04075643 | Sep 2019 | cardiovascular disorder | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03748212 Comparator | Oct → Dec 2018 | hypertensive disorder | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D935 | “Reference drug: D935 Test drug: CKD-385” NCT04075643 ↗ |
| Route | Oral | “single oral administration under fed condition” NCT03748212 ↗ |